Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00940927 · ClinicalTrials.gov registry record · Phase 4
Dose-response of Albuterol in Asthmatics
A Phase 4 study, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 81
- Enrollment target
NCT00940927: Completed Phase 4 study, sponsored by Nemours Children's Clinic.
NCT00940927 is a Phase 4 study that has completed, run by Nemours Children's Clinic. The registered enrollment target is 81 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00940927, a Phase 4 study, has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 81 participants
- Enrollment target
Study Summary
The purpose of this study was to determine the lung function response after increasing doses of albuterol (a bronchodilator) in children and adults with asthma.
Primary Outcome
ED50 is the cumulative dose of albuterol required to bring about 50% of maximum effect of albuterol
Interventions
- DRUG albuterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 1993-07 |
| Est. Completion | 1994-10 |
| Phase | Phase 4 |
What the finished NCT00940927 record still lists
NCT00940927 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 1 intervention - of which albuterol is the first listed.
NCT00940927 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00940927 about?
NCT00940927 is a clinical study titled "Dose-response of Albuterol in Asthmatics". The purpose of this study was to determine the lung function response after increasing doses of albuterol (a bronchodilator) in children and adults with asthma.
What is the current status of trial NCT00940927?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 81 participants. The study started on 1993-07. Estimated completion is 1994-10.
What interventions are being tested in trial NCT00940927?
The interventions under investigation include: albuterol (DRUG).
Who is sponsoring clinical trial NCT00940927?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00940927's enrollment target sits among peer trials
81 940th of 2000 higher than 1,055 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia